*[K+@~N&&;7|M~R]WFI.B8G
SYSTEM PROCESSING...
*[K+@~N&&;7|M~R]WFI.B8G
SYSTEM PROCESSING...
Posted: 2025-04-27 04:08:52 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-27 04:09:04 UTC
Verified By
Rollup News
KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confers resistance to AR-targeted therapy.
KMT2C deficiency
Transdifferentiation of double-negative prostate cancer
Resistance to AR-targeted therapy
Resistance to AR-targeted therapy